Common Dermatoses in Children Referred to a Specialized Pediatric Dermatology Service in Mexico: A Comparative Study

Blanca Rosa Del Pozzo-Magaña1, Alejandro Lazo-Langner, Pedro Gutiérrez-Castrellón

  • 1Department of Pediatric Dermatology, Instituto Nacional de Pediatría, 04530 Mexico City, DF, Mexico ; Division of Children's Health and Therapeutics, Children's Health Research Institute, London, ON, Canada N6C 2V5.

ISRN Dermatology
|October 26, 2012
PubMed

Insights

Pediatric skin disease frequencies have shifted over two decades, with conditions like atopic dermatitis and viral warts becoming more common in Mexican children. This study highlights changes in childhood dermatoses prevalence.

Area of Science:

  • Pediatric Dermatology
  • Epidemiology of Skin Diseases
  • Public Health

Background:

  • Childhood skin diseases differ from adult presentations.
  • Limited epidemiological data exists for pediatric dermatology in Mexico, with prior studies dating back 30 years.
  • Changes in disease frequency are anticipated due to evolving factors.

Purpose of the Study:

  • To investigate the current frequency of pediatric dermatoses.
  • To compare current findings with historical data from the same institution.
  • To identify shifts in the prevalence of skin conditions in children over time.

Main Methods:

  • Retrospective analysis of first-time patients at a pediatric dermatology service.
  • Data collection from January 1994 to December 2003.
  • Comparison of demographic data and diagnoses with a previous institutional study.

Main Results:

  • 5250 pediatric patients were included, with 6029 diagnoses recorded.
  • The most common dermatoses were atopic dermatitis (14.59%), viral warts (6.62%), and acne (5.53%).
  • A significant increase in the frequency of most dermatoses was observed compared to the previous study.

Conclusions:

  • The prevalence of pediatric skin diseases has changed significantly over the past two decades.
  • Environmental, sociocultural, and institutional factors likely contribute to these observed changes.
  • Updated epidemiological data is crucial for understanding current trends in pediatric dermatology.

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...